Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

The role of genotype and epigenotype in serotonin transporter effects on depression and anxiety-related behaviours

FY 2011-12

Summary
My proposed doctoral research project focuses on identifying mechanisms in the brain that influence vulnerability and resilience to anxiety and depression. Individual differences in the response to stress have profound effects on the risk for anxiety and depressive disorders. In Canada, one in 4 individuals suffers from anxiety or depression, disorders with large social and economic costs. Two potential mechanisms for individual differences in disease risk include gene by environment interactions and epigenetics. Epigenetic mechanisms can change in gene function in a long term manner without altering DNA sequence (i.e. genotype). A recent study done by the Fleming lab (where I plan to do my doctoral work) demonstrated that a naturally occurring genetic variation in the serotonin transporter gene (5HTT) in a rodent model, analogous to variation in 5HTT gene observed in humans, is associated with individual differences in the neuroendocrine response to stress, stress sensitive glucocorticoid receptor distribution in the brain's hippocampus and anxiety behaviour. Serotonin or drugs that enhance serotonin activity in brain cells grown in cellular culture significantly induce glucocorticoid gene expression and alter the gene in an epigenetic manner. Yet no study has examined the interaction between genotype and epigenotype in the regulation of gene expression and behaviour. I hypothesize that genetic differences in 5HTT confer differential stress responses at least in part via epigenetic modification of glucocorticoid receptor expression. I propose to study this phenomenon using pharmacological, molecular, and behavioural techniques. I will use rats that differ in 5HTT genotype to investigate evidence for (1) altered serotonin levels in the brain in basal and stress challenged conditions, (2) altered epigenetic status of the glucocorticoid receptor gene and (3) differential effects of drugs that alter serotonin activity in depression and anxiety-related behaviour
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
257542
Name
Sasaki Aya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of genotype and epigenotype in serotonin transporter effects on depression and anxiety-related behaviours
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Anxiety; Behavior; Depression; Epigenetics; Gene Environment Interactions; Genotype; Mental Health; Microdialysis; Rodent; Serotonin
Abstract
My proposed doctoral research project focuses on identifying mechanisms in the brain that influence vulnerability and resilience to anxiety and depression. Individual differences in the response to stress have profound effects on the risk for anxiety and depressive disorders. In Canada, one in 4 individuals suffers from anxiety or depression, disorders with large social and economic costs. Two potential mechanisms for individual differences in disease risk include gene by environment interactions and epigenetics. Epigenetic mechanisms can change in gene function in a long term manner without altering DNA sequence (i.e. genotype). A recent study done by the Fleming lab (where I plan to do my doctoral work) demonstrated that a naturally occurring genetic variation in the serotonin transporter gene (5HTT) in a rodent model, analogous to variation in 5HTT gene observed in humans, is associated with individual differences in the neuroendocrine response to stress, stress sensitive glucocorticoid receptor distribution in the brain's hippocampus and anxiety behaviour. Serotonin or drugs that enhance serotonin activity in brain cells grown in cellular culture significantly induce glucocorticoid gene expression and alter the gene in an epigenetic manner. Yet no study has examined the interaction between genotype and epigenotype in the regulation of gene expression and behaviour. I hypothesize that genetic differences in 5HTT confer differential stress responses at least in part via epigenetic modification of glucocorticoid receptor expression. I propose to study this phenomenon using pharmacological, molecular, and behavioural techniques. I will use rats that differ in 5HTT genotype to investigate evidence for (1) altered serotonin levels in the brain in basal and stress challenged conditions, (2) altered epigenetic status of the glucocorticoid receptor gene and (3) differential effects of drugs that alter serotonin activity in depression and anxiety-related behaviour
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sasaki, Aya
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~